$FMI Recent News Company worth watching tried
Post# of 102255
Company worth watching tried to help Apple's Steve Jobs battle cancer 6:35 p.m. Oct. 2, 2013 - Russ Britt
ASCO '14: Foundation Medicine Builds Case for Insurance Coverage 7:45 a.m. June 2, 2014 - TheStreet.com
Bull Thesis on Foundation Medicine: Using Big Data to Improve Treatment Decisions for Cancer Patients 8:08 p.m. May 28, 2014 - TheStreet.com
10-Q: FOUNDATION MEDICINE, INC. 6:06 a.m. May 13, 2014 - Edgar Online - (EDG = 10Q, 10K)
Foundation Medicine's (FMI) CEO Michael Pellini on Q1 2014 Results - Earnings Call Transcript 11:45 p.m. May 7, 2014 - Seeking Alpha
Notable earnings after Wednesday’s close 5:35 p.m. May 6, 2014 - Seeking Alpha
Foundation Med files for secondary offering 6:08 p.m. March 20, 2014 - Seeking Alpha
Foundation Medicine Lockup Expiration Could Flood The Market, Depressing Share Price 12:57 p.m. March 13, 2014 - Seeking Alpha
Fountain Medicine Lockup Expiration Could Flood The Market, Depressing Share Price 12:57 p.m. March 13, 2014 - Seeking Alpha
10-K: FOUNDATION MEDICINE, INC. 5:54 p.m. March 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Foundation Medicine's CEO Discusses Q4 2013 Results - Earnings Call Transcript 11:19 p.m. Feb. 25, 2014 - Seeking Alpha
Foundation Medicine: A Unique Cancer Play Backed By Google Ventures 12:29 p.m. Jan. 16, 2014 - Wall St. Cheat Sheet
Foundation Medicine: Undervalued As It Rewrites The Script On Cancer Treatment 4:27 p.m. Dec. 10, 2013 - Seeking Alpha
Foundation Medicine presents genomic profile data at ASH 10:00 a.m. Dec. 10, 2013 - Seeking Alpha
Not Your Father's Diagnostics: Ram Selvaraju On How Molecular Genomics Invigorate The Sector 5:27 p.m. Dec. 6, 2013 - Seeking Alpha
Cramer's Lightning Round - Maxim Has Been A Dog (11/15/13) 6:58 a.m. Nov. 17, 2013 - Seeking Alpha
10-Q: FOUNDATION MEDICINE, INC. 2:25 p.m. Nov. 12, 2013 - Edgar Online - (EDG = 10Q, 10K)
The New Science Behind Medical Investing 4:27 a.m. Oct. 19, 2013 - Barrons.com
Tech IPOs Hot As Investors OK With Companies In Red 5:53 p.m. Sept. 27, 2013 - Investors Business Daily
Foundation Medicine - Personalized Cancer Pharmaceutical IPO Fetches $1 Billion Valuation 11:36 a.m. Sept. 27, 2013 - Seeking Alpha
Cramer's Mad Money - 10 Stocks Money Managers Will Be Buying (9/26/13) 6:10 a.m. Sept. 27, 2013 - Seeking Alpha
Groundbreaking Collaborative Clinical Trial Launched 9:00 a.m. June 16, 2014 - PR Newswire - PRF
Earnings Adjustment, Financial Results, Upcoming Conferences, and Product Shipments - Analyst Notes on Agilent, Bio-Reference, RadNet, Foundation Medicine and Fluidigm 5:20 a.m. June 10, 2014 - PR Newswire - PRF
Foundation Medicine to Present at Upcoming Investor Conferences 6:30 a.m. June 4, 2014 - BusinessWire - BZX
FoundationOne® Identifies Clinically Relevant Alterations In Adolescent and Young Adult Solid Tumors 7:05 a.m. June 2, 2014 - BusinessWire - BZX
Foundation Medicine Identifies Actionable Genomic Alterations in Pediatric Cancers; New Clinical Data to be Presented at 2014 ASCO Annual Meeting 7:03 a.m. June 2, 2014 - BusinessWire - BZX
Foundation Medicine Announces Initial Data Demonstrating Clinical Utility of FoundationOne® in Advanced Solid Tumors; Clinical Data to Be Presented at 2014 ASCO Annual Meeting 9:01 a.m. May 31, 2014 - BusinessWire - BZX
CollabRx's Mobile App Simplifies Cancer Treatment Options 10:46 a.m. May 29, 2014 - ACCESSWIRE
Veracyte, Foundation Medicine and Panacea Global Paving Way in Faster, More Accurate Cancer Diagnostics 9:54 a.m. May 29, 2014 - ACCESSWIRE
Foundation Medicine and Collaborators to Present New Clinical Data on FoundationOne® and FoundationOne Heme at the 2014 ASCO Annual Meeting 5:01 p.m. May 14, 2014 - BusinessWire - BZX
Foundation Medicine Announces Key Developments in International Commercialization Efforts 6:31 a.m. May 12, 2014 - BusinessWire - BZX
Foundation Medicine Announces 2014 First Quarter Results and Recent Highlights 4:01 p.m. May 7, 2014 - BusinessWire - BZX
Foundation Medicine to Present at the Bank of America Merrill Lynch 2014 Healthcare Conference 4:31 p.m. May 6, 2014 - BusinessWire - BZX
The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives 7:37 p.m. May 5, 2014 - PR Newswire - PRF
CollabRx Partnership with Affymetrix Creates a Foundation 11:05 a.m. April 22, 2014 - ACCESSWIRE
Foundation Medicine Announces Timing for First Quarter 2014 Financial Results and Conference Call 6:31 a.m. April 16, 2014 - BusinessWire - BZX
Upcoming Financial Results, Recent Investments and Agreements, and Expanded Collaborations - Analyst Notes on PerkinElmer, PAREXEL, WuXi, Response Genetics, and Foundation Medicine 8:00 a.m. April 9, 2014 - PR Newswire - PRF
Foundation Medicine and Clovis Oncology Expand Collaboration to Develop Novel Companion Diagnostic for Rucaparib in Ovarian Cancer 6:30 a.m. April 3, 2014 - BusinessWire - BZX
Foundation Medicine Announces New Data Highlighting FoundationOne™ and FoundationOne™ Heme to be Presented at the AACR Annual Meeting 2014 6:31 a.m. April 2, 2014 - BusinessWire - BZX
CollabRx: Making Sense of the Complex Cancer Market 10:02 a.m. April 1, 2014 - ACCESSWIRE
Regulatory Approvals, Pricing of Public Offering, Stock Price Movements, and Financial Reports - Analyst Notes on Arrowhead, ANI, OraSure, Rigel, and Foundation Medicine 12:30 p.m. March 10, 2014 - PR Newswire - PRF